# RIFABUTIN
> **ANDA215041** · Abbreviated New Drug Application (Generic) · Sponsor: NOVITIUM PHARMA · Approved 2021-12-17
## Drug
- **FDA Application Number:** ANDA215041
- **Application type:** Abbreviated New Drug Application (Generic)
- **Brand name:** RIFABUTIN
- **Generic name:** RIFABUTIN
- **Active ingredients:** RIFABUTIN
- **Dosage form:** CAPSULE
- **Route:** ORAL
- **Marketing status:** Prescription
- **Sponsor:** NOVITIUM PHARMA
- **Manufacturer:** ANI Pharmaceuticals, Inc.
- **First approval:** 2021-12-17
## Source
- [Drugs@FDA application overview](https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=215041)
---
*MORVS · CC0 1.0*